Swiss Re China Cancer Forum
From vision to resilience towards Healthy China 2030
Date | 24 Oct 2019 |
---|---|
Location | The Peninsula Beijing 8 Goldfish Lane, Wangfujing, Beijing Click to open Google Maps |
Tab navigation
About the event
Cancer is one of the most prominent health challenges we face today. In 2018, it is estimated that 18 million persons were diagnosed with cancer world-wide. In China, the age standardisation rate for cancer was a little over 200 per 100,000 inhabitants – a figure likely to grow significantly as the population ages.
With China's rapidly ageing population and shifts in lifestyle, rates of cancer and other non-communicable diseases are steeply on the rise. Consumers are increasingly looking for solutions to cope with the risk of cancer and sales of critical illness products have increased sharply in China.
This is a great opportunity for insurers but not one without risk. While medical and technological advancements have made access to cancer screening and early detection more convenient for consumers, are insurers ready to manage the potential implications of asymmetrical information disclosure? Are health and medical service providers ready to cope with rising demand for cancer treatment?
Agenda
Venue: The Peninsula Beijing |
|
09:30 |
Registration and welcome coffee |
10:00 |
Welcome address |
10:10 |
Swiss Re Institute and R&D in China |
10:20 |
L&H products supervision and product innovation trends in China |
10:50 |
Understanding cancer and cancer medicine from public opinion perspectives |
11:20 |
The disease burden of malignant tumor in China |
11:50 |
Lunch break |
13:00 |
Breakout sessions – Round I 1) Medical imaging based on AI |
13:45 |
Short break |
13:55 |
Breakout sessions – Round II |
14:40 |
Coffee break |
15:10 |
Implications of the changing cancer landscape for insurers |
15:40 |
Panel discussion: Smarter together for a new era of critical illness Panelists: |
16:25 |
Closing remarks |
16:30 |
Apero |
17:30 |
End of event |
Speakers

Yuan Bin
Chief Actuary, Head of Product Actuarial Department & Reinsurance Department
RongSheng P&C Insurance Company, Neusoft Group

Yue Cai
Associate Research Fellow
Statistics Department under the National Health Commission (NHC)
Yuan Cao
Vice president
Infervision Technology Co. Ltd.

John Chen
Head China
Asia

Peichan Chen
Head of Public Opinion Monitoring Center
China Health Media Group (CHMG)

Wanqing Chen
Director
Office of Cancer Screening, National Cancer Center

Winnie Ching
Head Life & Health North Asia
Asia

Russell Higginbotham
Chief Executive Officer Reinsurance Asia
Hairong Huang
Head SRI Centre China
Swiss Re Institute

Daisy Ning
Head Life & Health Products Asia
Life & Health Products

Haoran Peng
Professor of Finance at Lingnan College
Sun Yat-sen University

Guozheng Ren
Researcher of the International Institute on Green Finance of CUFE
Lawrence Tsui
Chief Pricing Officer L&H Products
Life & Health Products
Siyang Wang
Chairwoman and founder
Aijiazaocha Company

Li Xing
Deputy Head SRI Centre China
Swiss Re Institute

David Zhang
Head Client Markets L&H China
Asia
Presentations
From Vision to Resilience, heading Healthy China 2030
John Chen, President Swiss Re China
Winnie Ching, Head Life & Health North Asia, Swiss Re
Hairong Huang, Head Swiss Re Institute China Centre
Reflection on the development of healthcare economy from the perspective of cancer
Prof. Guozheng Ren, Central University of Finance and Economics
Implications of the changing cancer landscape for insurers
Lawrence Tsui, Chief Pricing Officer L&H Products, Swiss Re
Gallery
Photos by Sun Chen
Contact

Swiss Re Institute
Superior research driving better decisions